Over 80% of enterprise data today is unstructured1 including text, voice, image or pdf files, and their volume continues to expand.
Converting big data into meaningful information is a growing challenge. For pharma and healthcare, making sense of unstructured data presents an opportunity to get a deeper understanding of patients, physicians, and other stakeholders. Processing, managing and utilizing these untapped assets has been made possible by artificial intelligence (AI), big data technologies and advanced analytics like Machine Learning (ML) and Natural Language Processing (NLP).
Axtria’s use case showcases the use of ML/NLP to capture biomarker data and other biographic information from scanned Electronic Health Records (EHR) and Electronic Medical Records (EMR) for a diversified healthcare company to:
Download the case study to understand Axtria’s approach to analyze ~7 terabytes of unstructured data.